TITLE

CLINIC ROUNDUP

PUB. DATE
July 2009
SOURCE
BioWorld Today;7/15/2009, Vol. 20 Issue 134, p6
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
This section offers news briefs related to several clinical trials. A Phase I/II trial with CF102 for the treatment of hepatitis C virus by Can-Fite BioPharma of Petach Tikva, Israel will begin to enroll patients. Enrollment for the first of two ongoing blinded, placebo-controlled, multicenter, parallel group studies of AZX100 by Capstone Therapeutics of Tempe, Arizona has been completed. A Phase I study has been initiated by Keryx Biopharmaceuticals Inc. to evaluate the KRX-0401 anticancer agent.
ACCESSION #
43236105

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics